Cofares has established itself as a benchmark in the pharmaceutical distribution industry. If in 2021 they billed about $3,600 million and had a market share of 29%, then their figures in 2022 rose to 4,000 million accounts, a record high, and a quota of 30%.

The company, headed by Eduardo Pastor, was established in 1944, is headquartered in Alcobendas and owns its capital 100% in the hands of legally protected pharmaceutical partners. Besides, brings together brands such as Farmavenix or Profarcowhich contains all Cofares stores.

Andalusian follows in the distance Bidafarma, led by Antonio Mingorans of Granada, who owns 21.74% of the shares market. The firm was founded in 2016, has 100% pharmaceutical capital without government protection and is the result of a merger of 12 cooperatives.

Bidapharma invoiced for approximately EUR 2,600 millioncompared to €2,536 million achieved in 2020. The company has not yet entered the corresponding invoices into the commercial register for 2021, but reports these figures on its website.

From my side, Hefame, led by Enrique Ayuso, a group based in Murcia, is the third company with a market share of 11.05%. in 2021. In the same year, the firm’s turnover was 1,455 million euros, compared to 1,411 million euros in 2020.

On the fourth position of Alliance Healthcare, the group, owned by the Americans AmerisourceBergen, reaches a share of 10.37%. The company is based in Zaragoza and reported 2021 revenue of €1,275 million, up from €1,201 in 2020.

These four companies represent more than 70% of the entire market.. The turnover of all of them combined exceeds 12,000 million euros in 2021, with a total of more than 22,000 pharmacies; according to information made public by the distributors themselves and the Commercial Register.

this week sector meets in full, 30,000 specialists are expected, in the INFARMA hall Fira de Barcelona, ​​and experts believe that the distribution has already completely returned to normal after years of the pandemic; and with a corresponding growth expectation.

This sector is undoubtedly strategic for Spanish society, and this is recognized in Brussels, where the European Parliament stated in its report of the Committee on Civil Liberties, Justice and Home Affairs that pharmaceutical distributors are “essential services to the public”. The Spanish pharmaceutical model is considered one of the best in the world. One of the most efficient and with a strong social commitment.